>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

November 07, 2014

FDA MedWatch - Nellcor Puritan Bennett, 980 Ventilator System: Class I Recall - Software Issue May Stop Ventilator

Summary:

FDA MedWatch Nellcor Puritan Bennett 980 Ventilator System Class I Recall

October 25, 2014

FDA MedWatch - Intravia Containers by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Intravia Containers by Baxter Recall

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Submits Letter to DEA Supporting the Scheduling of Propofol

Thursday, December 23, 2010

In a letter sent to the Drug Enforcement Administration (DEA), ASA expresses its strong support for the DEA’s proposal to place propofol into schedule IV of the Controlled Substances Act and its belief that schedule IV is the proper schedule for the drug. While ASA is extremely supportive of DEA’s proposal, ASA also reminded the Agency that the U.S. health care system and the anesthesia community in particular, are currently recovering from a nationwide shortage of propofol and other related induction agents. Therefore ASA urged the Agency to carefully consider the impact scheduling will have on the supply and distribution of propofol in the near-term in order to avoid unnecessary shortages that could hamper anesthesiologists ability to provide safe patient care. 

Click here to read the full letter.

« Back to Washington Alerts